Products with Inhibitors bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN1987 | Macrophylline |
| 1. Macrophylline A shows weak inhibitory action on KCl-induced contraction. | |
| BCN2003 | Loline |
| 1. Loline can reduce prolactin release at the highest concentration, 10(-4) M. | |
| BCN2034 | Retronecine |
| 1. Retronecine can be metabolized to form DHP by rat liver microsomal enzymes and interacts with DNA to produce DHP-DNA adducts and Retronecine N-oxide undergoes the biotransformation to the parent compound, Retronecine. 2. Retronecine acts as the better competitor for the competitive inhibition of antibodies to Retronecine. | |
| BCN2123 | Retusine |
| 1. Retusine has edema inhibition capacity, could be related to a reduction of the prostaglandin production. 2. Retusine shows activity against the Gram-positive bacteria C. diphtheria and S. aureus. | |
| BCN2160 | Sodium barbital |
| 1. Sodium barbital was used as a model non-genotoxic renal carcinogen to test whether a concentration that increased renal tubular proliferation without severe nephrotoxicity would enhance tumor induction in a hereditary tumor model. 2. Sodium barbital causes progression to the stage of spontaneous renal lesions in Tsc2 mutant rats but do not increase their overall number. 3. Sodium barbital is a depressant of the central nervous system, has sedative/hypnotic effects. 4. Sodium barbital as an inhibitor of rabbit-muscle creatine kinase (CK), it might compete with both creatine and ATP, but mainly with creatine, to inhibit the activity of CK. 5. Sodium barbital is a tumour promoter, it can shorten the otherwise long latency between exposure to toxin and tumourigenesis. | |
